11:33:01 EDT Fri 03 May 2024
Enter Symbol
or Name
USA
CA



Curaleaf Holdings Inc
Symbol CURA
Shares Issued 630,938,502
Close 2023-09-28 C$ 6.08
Market Cap C$ 3,836,106,092
Recent Sedar Documents

Curaleaf prices $16.2-million financing at $6 a share

2023-09-28 10:21 ET - News Release

Mr. Camilo Lyon reports

CURALEAF ANNOUNCES C$16 MILLION UNDERWRITTEN OFFERING OF SUBORDINATE VOTING SHARES

Curaleaf Holdings Inc. has priced its previously announced marketed offering of subordinate voting shares of the company at a price of $6 per offered security. Canaccord Genuity Corp., which is acting as the sole underwriter and bookrunner for the offering, has agreed to purchase 2.7 million offered securities from the company for total gross proceeds to the company of $16.2-million.

The offered securities will be offered in each province of Canada, other than Quebec, pursuant to a prospectus supplement to the company's base shelf prospectus dated Dec. 30, 2022, and in the United States on a private placement basis to qualified institutional buyers, pursuant to exemptions from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws. The prospectus supplement is expected to be filed on Sept. 28, 2023.

The closing date of the offering is expected to be Oct. 3, 2023, and will be subject to market and other customary conditions, including requirements of the Canadian Securities Exchange.

The company is making the offering to satisfy a condition required for a potential listing of the subordinate voting shares on the Toronto Stock Exchange, and plans to use a portion of the proceeds of the offering: (i) to finance working capital requirements of its international business operated by Curaleaf Holdings International; and (ii) for general corporate purposes of the company.

Copies of the prospectus, following the filing thereof, may be obtained on SEDAR+ under the company's profile and from Canaccord Genuity, 40 Temperance St., suite 2100, Toronto, Ont., M5H 0B4. The prospectus will contain important detailed information about the company and the proposed offering. Prospective investors should read the prospectus and the other documents the company has filed under its issuer profile on SEDAR+ before making an investment decision.

About Curaleaf Holdings Inc.

Curaleaf is a leading international provider of consumer products in cannabis, with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, including Curaleaf, Select and Grassroots, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 19 states with 152 dispensaries, and employs nearly 5,500 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe, with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.